🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquarePCOS and GLP-1 agonists — reproductive outcomes data Page 3

PCOS and GLP-1 agonists — reproductive outcomes data

MeganSA_TX Sat, Mar 28, 2026 at 6:28 AM 17 replies 787 viewsPage 3 of 4
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Mar 28, 2026 at 8:21 PM#11
GenomicsKate said:
It helps to ask what evidence would change your mind before you look at any.

Genuinely useful, thank you. I had the facts and not the framework.

Last edited: Mar 28, 2026 at 9:21 PM
25 23Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 22 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Mar 29, 2026 at 3:58 AM#12

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

26 24dave_SLC, FDA_TrackerJim, ricardo_MIA and 23 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 29, 2026 at 11:35 AM#13
DebRD_ATL said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

27 0maya_sedona, stefan_berlin, Dr.EM_Chicago and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Mar 29, 2026 at 7:12 PM#14

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Mar 29, 2026 at 11:12 PM
28 1fiona_VT, denise_HTX, raj_cambridge and 25 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 30, 2026 at 2:49 AM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Report rather than reply if it drifts again.

29 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 26 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register